Intravascular ultrasound imaging for assessing regression and progression in coronary artery disease

American Journal of Cardiology

Volumn 106, Issue 12, 2010, Pages 1735-1746

  Kaneda, Hideaki ^a,b   Ako, Junya ^c   Terashima, Mitsuyasu ^d  

^a Okinaka Memorial Institute for Medical Research   (Japan)

^b Department of Cardiology Tokyo Heart Center   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d Toyohashi Heart Center Toyohashi   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; APOLIPOPROTEIN A1; ATORVASTATIN; AVASIMIBE; DARAPLADIB; ENALAPRIL; ETC 216; GLIMEPIRIDE; NIFEDIPINE; PACTIMIBE; PERINDOPRIL; PIOGLITAZONE; PRAVASTATIN; PROBUCOL; PROBUCOL SUCCINATE; RIMONABANT; ROSUVASTATIN; SIMVASTATIN; TORCETRAPIB;

ARTICLE; ATHEROSCLEROTIC PLAQUE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE COURSE; HUMAN; INTRAVASCULAR ULTRASOUND; PRIORITY JOURNAL;

EID: 78649692442     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.08.012     Document Type: Review

References (46)

1. E.M. Balk, R.H. Karas, H.S. Jordan, B. Kupelnick, P. Chew, and J. Lau Effects of statins on vascular structure and function: a systematic review Am J Med 117 2004 775 790
2. D.E. Grobbee, and M.L. Bots Atherosclerotic disease regression with statins: studies using vascular markers Int J Cardiol 96 2004 447 459
3. G.A. Rodriguez-Granillo, P. Agostoni, H.M. Garcia-Garcia, G.G. Biondi-Zoccai, E. Mc Fadden, G. Amoroso, P. de Jaegere, N. Bruining, P. de Feyter, and P.W. Serruys Meta-analysis of the studies assessing temporal changes in coronary plaque volume using intravascular ultrasound Am J Cardiol 99 2007 5 10
4. K.A. Robinson, and K. Dickersin Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed Int J Epidemiol 31 2002 150 153
5. M. Egger, G. Davey Smith, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
6. T. Takagi, K. Yoshida, T. Akasaka, T. Hozumi, S. Morioka, and J. Yoshikawa Intravascular ultrasound analysis of reduction in progression of coronary narrowing by treatment with pravastatin Am J Cardiol 79 1997 1673 1676
7. M. Schartl, W. Bocksch, D.H. Koschyk, W. Voelker, K.R. Karsch, J. Kreuzer, D. Hausmann, S. Beckmann, and M. Gross Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease Circulation 104 2001 387 392
8. J.C. Tardif, J. Gregoire, L. Schwartz, L. Title, L. Laramee, F. Reeves, J. Lesperance, M.G. Bourassa, P.L. L'Allier, M. Glass, J. Lambert, and M.C. Guertin Effects of AGI-1067 and probucol after percutaneous coronary interventions Circulation 107 2003 552 558
9. S.E. Nissen, T. Tsunoda, E.M. Tuzcu, P. Schoenhagen, C.J. Cooper, M. Yasin, G.M. Eaton, M.A. Lauer, W.S. Sheldon, C.L. Grines, S. Halpern, T. Crowe, J.C. Blankenship, and R. Kerensky Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial JAMA 290 2003 2292 2300
10. S.E. Nissen, E.M. Tuzcu, P. Schoenhagen, B.G. Brown, P. Ganz, R.A. Vogel, T. Crowe, G. Howard, C.J. Cooper, B. Brodie, C.L. Grines, and A.N. DeMaria Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial JAMA 291 2004 1071 1080 (Pubitemid 38541684)
11. S. Okazaki, T. Yokoyama, K. Miyauchi, K. Shimada, T. Kurata, H. Sato, and H. Daida Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study Circulation 110 2004 1061 1068
12. S.E. Nissen, E.M. Tuzcu, P. Libby, P.D. Thompson, M. Ghali, D. Garza, L. Berman, H. Shi, E. Buebendorf, and E.J. Topol Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial JAMA 292 2004 2217 2225
13. J.C. Tardif, J. Gregoire, P.L. L'Allier, T.J. Anderson, O. Bertrand, F. Reeves, L.M. Title, F. Alfonso, E. Schampaert, A. Hassan, R. McLain, M.L. Pressler, R. Ibrahim, J. Lesperance, J. Blue, T. Heinonen, and J. Rodes-Cabau Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions Circulation 110 2004 3372 3377
14. A.S. Petronio, G. Amoroso, U. Limbruno, B. Papini, M. De Carlo, A. Micheli, N. Ciabatti, and M. Mariani Simvastatin does not inhibit intimal hyperplasia and restenosis but promotes plaque regression in normocholesterolemic patients undergoing coronary stenting: a randomized study with intravascular ultrasound Am Heart J 149 2005 520 526
15. M. Kawasaki, K. Sano, M. Okubo, H. Yokoyama, Y. Ito, I. Murata, K. Tsuchiya, S. Minatoguchi, X. Zhou, H. Fujita, and H. Fujiwara Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound J Am Coll Cardiol 45 2005 1946 1953
16. M. Yokoyama, N. Komiyama, B.K. Courtney, T. Nakayama, S. Namikawa, N. Kuriyama, T. Koizumi, M. Nameki, P.J. Fitzgerald, and I. Komuro Plasma low-density lipoprotein reduction and structural effects on coronary atherosclerotic plaques by atorvastatin as clinically assessed with intravascular ultrasound radio-frequency signal analysis: a randomized prospective study Am Heart J 150 2005 287
17. S. Tani, I. Watanabe, T. Anazawa, H. Kawamata, E. Tachibana, K. Furukawa, Y. Sato, K. Nagao, K. Kanmatsuse, and T. Kushiro Effect of pravastatin on malondialdehyde-modified low-density lipoprotein levels and coronary plaque regression as determined by three-dimensional intravascular ultrasound Am J Cardiol 96 2005 1089 1094
18. S.E. Nissen, E.M. Tuzcu, H.B. Brewer, I. Sipahi, S.J. Nicholls, P. Ganz, P. Schoenhagen, D.D. Waters, C.J. Pepine, T.D. Crowe, M.H. Davidson, J.E. Deanfield, L.M. Wisniewski, J.J. Hanyok, and L.M. Kassalow Effect of ACAT inhibition on the progression of coronary atherosclerosis N Engl J Med 354 2006 1253 1263
19. S.E. Nissen, J.C. Tardif, S.J. Nicholls, J.H. Revkin, C.L. Shear, W.T. Duggan, W. Ruzyllo, W.B. Bachinsky, G.P. Lasala, and E.M. Tuzcu Effect of torcetrapib on the progression of coronary atherosclerosis N Engl J Med 356 2007 1304 1316
20. J.C. Tardif, J. Gregoire, P.L. L'Allier, R. Ibrahim, J. Lesperance, T.M. Heinonen, S. Kouz, C. Berry, R. Basser, M.A. Lavoie, M.C. Guertin, and J. Rodes-Cabau Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial JAMA 297 2007 1675 1682
21. G.A. Rodriguez-Granillo, J. Vos, N. Bruining, H.M. Garcia-Garcia, S. de Winter, J.M. Ligthart, J.W. Deckers, M. Bertrand, M.L. Simoons, R. Ferrari, K.M. Fox, W. Remme, and P.J. De Feyter Long-term effect of perindopril on coronary atherosclerosis progression (from the perindopril's prospective effect on coronary atherosclerosis by angiography and intravascular ultrasound evaluation [PERSPECTIVE] study) Am J Cardiol 100 2007 159 163
22. T. Yamada, A. Azuma, S. Sasaki, T. Sawada, and H. Matsubara Randomized evaluation of atorvastatin in patients with coronary heart disease: a serial intravascular ultrasound study Circ J 71 2007 1845 1850
23. J.C. Tardif, J. Gregoire, P.L. L'Allier, R. Ibrahim, T.J. Anderson, F. Reeves, L.M. Title, E. Schampaert, M. LeMay, J. Lesperance, R. Scott, M.C. Guertin, M.L. Brennan, S.L. Hazen, and O.F. Bertrand Effects of the antioxidant succinobucol (AGI-1067) on human atherosclerosis in a randomized clinical trial Atherosclerosis 197 2008 480 486
24. S.E. Nissen, S.J. Nicholls, K. Wolski, J. Rodes-Cabau, C.P. Cannon, J.E. Deanfield, J.P. Despres, J.J. Kastelein, S.R. Steinhubl, S. Kapadia, M. Yasin, W. Ruzyllo, C. Gaudin, B. Job, B. Hu, D.L. Bhatt, A.M. Lincoff, and E.M. Tuzcu Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial JAMA 299 2008 1547 1560
25. S.E. Nissen, S.J. Nicholls, K. Wolski, R. Nesto, S. Kupfer, A. Perez, H. Jure, R. De Larochelliere, C.S. Staniloae, K. Mavromatis, J. Saw, B. Hu, A.M. Lincoff, and E.M. Tuzcu Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial JAMA 299 2008 1561 1573 (Pubitemid 351482795)
26. P.W. Serruys, H.M. Garcia-Garcia, P. Buszman, P. Erne, S. Verheye, M. Aschermann, H. Duckers, O. Bleie, D. Dudek, H.E. Botker, C. von Birgelen, D. D'Amico, T. Hutchinson, A. Zambanini, F. Mastik, G.A. van Es, A.F. van der Steen, D.G. Vince, P. Ganz, C.W. Hamm, W. Wijns, and A. Zalewski Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque Circulation 118 2008 1172 1182
27. D. Ogasawara, J. Shite, T. Shinke, S. Watanabe, H. Otake, Y. Tanino, T. Sawada, H. Kawamori, H. Kato, N. Miyoshi, and K. Hirata Pioglitazone reduces the necrotic-core component in coronary plaque in association with enhanced plasma adiponectin in patients with type 2 diabetes mellitus Circ J 73 2009 343 351
28. T.F. Luscher, M. Pieper, M. Tendera, M. Vrolix, W. Rutsch, F. van den Branden, R. Gil, K.O. Bischoff, M. Haude, D. Fischer, T. Meinertz, and T. Munzel A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study Eur Heart J 30 2009 1590 1597
29. M.K. Hong, D.W. Park, C.W. Lee, S.W. Lee, Y.H. Kim, D.H. Kang, J.K. Song, J.J. Kim, S.W. Park, and S.J. Park Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis JACC Cardiovasc Interv 2 2009 679 688
30. T. Hiro, T. Kimura, T. Morimoto, K. Miyauchi, Y. Nakagawa, M. Yamagishi, Y. Ozaki, K. Kimura, S. Saito, T. Yamaguchi, H. Daida, and M. Matsuzaki Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome] study) J Am Coll Cardiol 54 2009 293 302
31. T. Toi, I. Taguchi, S. Yoneda, M. Kageyama, A. Kikuchi, M. Tokura, T. Kanaya, S. Abe, R. Matsuda, and N. Kaneko Early effect of lipid-lowering therapy with pitavastatin on regression of coronary atherosclerotic plaque Circ J 73 2009 1466 1472
32. T. Nakayama, N. Komiyama, M. Yokoyama, S. Namikawa, N. Kuroda, Y. Kobayashi, and I. Komuro Pioglitazone induces regression of coronary atherosclerotic plaques in patients with type 2 diabetes mellitus or impaired glucose tolerance: A randomized prospective study using intravascular ultrasound Int J Cardiol 138 2010 157 165
33. K.M. Fox Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) Lancet 362 2003 782 788
34. C.P. Cannon, E. Braunwald, C.H. McCabe, D.J. Rader, J.L. Rouleau, R. Belder, S.V. Joyal, K.A. Hill, M.A. Pfeffer, and A.M. Skene Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 2004 1495 1504
35. P.J. Barter, M. Caulfield, M. Eriksson, S.M. Grundy, J.J. Kastelein, M. Komajda, J. Lopez-Sendon, L. Mosca, J.C. Tardif, D.D. Waters, C.L. Shear, J.H. Revkin, K.A. Buhr, M.R. Fisher, A.R. Tall, and B. Brewer Effects of torcetrapib in patients at high risk for coronary events N Engl J Med 357 2007 2109 2122
36. P.A. Poole-Wilson, J. Lubsen, B.A. Kirwan, F.J. van Dalen, G. Wagener, N. Danchin, H. Just, K.A. Fox, S.J. Pocock, T.C. Clayton, M. Motro, J.D. Parker, M.G. Bourassa, A.M. Dart, P. Hildebrandt, A. Hjalmarson, J.A. Kragten, G.P. Molhoek, J.E. Otterstad, R. Seabra-Gomes, J. Soler-Soler, and S. Weber Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial Lancet 364 2004 849 857
37. J.C. Tardif, J.J. McMurray, E. Klug, R. Small, J. Schumi, J. Choi, J. Cooper, R. Scott, E.F. Lewis, P.L. L'Allier, and M.A. Pfeffer Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial Lancet 371 2008 1761 1768
38. C. Baigent, A. Keech, P.M. Kearney, L. Blackwell, G. Buck, C. Pollicino, A. Kirby, T. Sourjina, R. Peto, R. Collins, and R. Simes Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278
39. J.A. Dormandy, B. Charbonnel, D.J. Eckland, E. Erdmann, M. Massi-Benedetti, I.K. Moules, A.M. Skene, M.H. Tan, P.J. Lefebvre, G.D. Murray, E. Standl, R.G. Wilcox, L. Wilhelmsen, J. Betteridge, K. Birkeland, A. Golay, R.J. Heine, L. Koranyi, M. Laakso, M. Mokan, A. Norkus, V. Pirags, T. Podar, A. Scheen, W. Scherbaum, G. Schernthaner, O. Schmitz, J. Skrha, U. Smith, and J. Taton Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive study (Prospective Pioglitazone Clinical Trial in Macrovascular Events): a randomised controlled trial Lancet 366 2005 1279 1289
40. Y.S. Chatzizisis, A.U. Coskun, M. Jonas, E.R. Edelman, C.L. Feldman, and P.H. Stone Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior J Am Coll Cardiol 49 2007 2379 2393
41. G. Pasterkamp, P.J. Wensing, M.J. Post, B. Hillen, W.P. Mali, and C. Borst Paradoxical arterial wall shrinkage may contribute to luminal narrowing of human atherosclerotic femoral arteries Circulation 91 1995 1444 1449
42. K. Tanaka, S.G. Carlier, G.S. Mintz, K. Sano, X. Liu, K. Fujii, J. de Ribamar Costa Jr, J. Lui, J.W. Moses, G.W. Stone, and M.B. Leon The accuracy of length measurements using different intravascular ultrasound motorized transducer pullback systems Int J Cardiovasc Imaging 23 2007 733 738
43. P. Juni, D.G. Altman, and M. Egger Systematic reviews in health care: assessing the quality of controlled clinical trials BMJ 323 2001 42 46
44. S. Kaul, and G.A. Diamond Good enough: a primer on the analysis and interpretation of noninferiority trials Ann Intern Med 145 2006 62 69
45. A.L. Gould, J. Koglin, R.P. Bain, C.A. Pinto, Y.B. Mitchel, R.C. Pasternak, and A. Sapre Effects of sources of variability on sample sizes required for RCTs, applied to trials of lipid-altering therapies on carotid artery intima-media thickness Clin Trials 6 2009 305 319
46. T.R. Fleming, and D.L. DeMets Surrogate end points in clinical trials: are we being misled? Ann Intern Med 125 1996 605 613